QUALITY-OF-LIFE ASSESSMENTS AND LEVELS OF DECISION-MAKING - DIFFERENTIATING OBJECTIVES

被引:37
作者
SUTHERLAND, HJ
TILL, JE
机构
[1] UNIV TORONTO,CTR BIOETH,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
DECISION MAKING; PREFERENCES; HEALTH PROFILES; UTILITY MEASUREMENT; QUALITY OF LIFE;
D O I
10.1007/BF00434801
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this paper is to examine uses of quality of life (QOL) measurements at different levels of decision making within the health care system, ranging from the micro (clinical) level, through the meso (agency, institutional or regional) level to the macro and meta (governmental) levels. We use individualized, group and population-based QOL and preference assessments as illustrative examples of ways in which QOL information and decision making level interact. We conclude that the meso and macro levels pose particularly challenging problems, and suggest that, if the primary emphasis is placed on applications of QOL assessments at the micro (clinical) level of decision making, a research agenda that is much too limited may be adopted.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 37 条
[1]  
Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949
[2]  
BAROFSKY I, 1992, QUALITY LIFE CANCER, P7
[3]   IS THE OREGON RATIONING PLAN FAIR [J].
DANIELS, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (17) :2232-2235
[4]  
EBELL MH, 1990, J FAM PRACTICE, V31, P630
[5]  
Emanuel Ezekial, 1991, ENDS HUMAN LIFE MED
[6]  
Field MJ, 1992, GUIDELINES CLIN PRAC
[7]   METHODOLOGY FOR MEASURING HEALTH-STATE PREFERENCES .2. SCALING METHODS [J].
FROBERG, DG ;
KANE, RL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (05) :459-471
[8]  
KAPLAN R, 1992, RATIONING AM MED CAR, P60
[9]  
KAPLAN RM, 1988, HEALTH SERV RES, V23, P203
[10]   THE IMPACT OF BREAST-CONSERVING TREATMENT AND MASTECTOMY ON THE QUALITY-OF-LIFE OF EARLY-STAGE BREAST-CANCER PATIENTS - A REVIEW [J].
KIEBERT, GM ;
DEHAES, JCJM ;
VANDEVELDE, CJH .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) :1059-1070